These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 8375430

  • 1. Type B monoamine oxidase and neurotoxins.
    Naoi M, Maruyama W.
    Eur Neurol; 1993; 33 Suppl 1():31-7. PubMed ID: 8375430
    [Abstract] [Full Text] [Related]

  • 2. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
    Naoi M, Dostert P, Yoshida M, Nagatsu T.
    Adv Neurol; 1993; 60():212-7. PubMed ID: 8420137
    [Abstract] [Full Text] [Related]

  • 3. Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase?
    Sandler M, Glover V, Clow A, Jarman J.
    Adv Neurol; 1993; 60():238-41. PubMed ID: 8420141
    [No Abstract] [Full Text] [Related]

  • 4. Pathogenesis and animal studies of Parkinson's disease.
    Oertel WH, Kupsch A.
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
    [Abstract] [Full Text] [Related]

  • 5. Activity of Monoamine Oxidase in the Nigrostriatal System at Presymptomatic and Early Symptomatic Stages of Parkinsonism in Mice.
    Khakimova GR, Kozina EA, Buneeva OA, Aksenova LN, Medvedev AE, Ugryumov MV.
    Bull Exp Biol Med; 2015 Aug; 159(4):456-8. PubMed ID: 26388575
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Are free radicals involved in the pathogenesis of idiopathic Parkinson's disease?
    Poirier J, Thiffault C.
    Eur Neurol; 1993 Aug; 33 Suppl 1():38-43. PubMed ID: 8375431
    [Abstract] [Full Text] [Related]

  • 8. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
    Naoi M, Maruyama W, Kasamatsu T, Dostert P.
    J Neural Transm Suppl; 1998 Aug; 52():125-38. PubMed ID: 9564615
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxicity of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines.
    Maruyama W, Takahashi T, Minami M, Takahashi A, Dostert P, Nagatsu T, Naoi M.
    Adv Neurol; 1993 Aug; 60():224-30. PubMed ID: 8093579
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Deleu D.
    Acta Neurol Belg; 1998 Dec; 98(4):319-21. PubMed ID: 9922818
    [No Abstract] [Full Text] [Related]

  • 12. The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson's disease.
    Youdim MB, Riederer P.
    Mov Disord; 1993 Dec; 8 Suppl 1():S8-13. PubMed ID: 8302308
    [Abstract] [Full Text] [Related]

  • 13. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P, Marsden CD.
    J Neural Transm Suppl; 1986 Dec; 20():11-39. PubMed ID: 3091760
    [Abstract] [Full Text] [Related]

  • 14. Nigral degeneration in Parkinson's disease.
    Rinne JO.
    Mov Disord; 1993 Dec; 8 Suppl 1():S31-5. PubMed ID: 8302305
    [Abstract] [Full Text] [Related]

  • 15. Metabolic aspects of the behavior of MPTP and some analogues.
    Tipton KF, McCrodden JM, Sullivan JP.
    Adv Neurol; 1993 Dec; 60():186-93. PubMed ID: 8420134
    [No Abstract] [Full Text] [Related]

  • 16. Selegiline can mediate neuronal rescue rather than neuronal protection.
    Tatton WG.
    Mov Disord; 1993 Dec; 8 Suppl 1():S20-30. PubMed ID: 8302304
    [Abstract] [Full Text] [Related]

  • 17. Amine-related neurotoxins in Parkinson's disease: past, present, and future.
    Nagatsu T.
    Neurotoxicol Teratol; 2002 Dec; 24(5):565-9. PubMed ID: 12200187
    [Abstract] [Full Text] [Related]

  • 18. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Dec; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 19. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
    Naoi M, Maruyama W, Dostert P, Hashizume Y.
    J Neural Transm Suppl; 1997 Dec; 50():89-105. PubMed ID: 9120428
    [Abstract] [Full Text] [Related]

  • 20. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
    Di Monte DA, McCormack A, Petzinger G, Janson AM, Quik M, Langston WJ.
    Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.